Tasly Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 17,989.536 million compared to CNY 16,094.149 million a year ago. Operating income was CNY 1,944.785 million compared to CNY 1,744.504 million a year ago. Net income was CNY 1,545.167 million compared to CNY 1,376.542 million a year ago. Basic earnings per share from continuing operations was CNY 1.02 compared to CNY 0.91 a year ago.